Advertisement

Product › Details
DRUGS, BIOGEN, GENERICS (biosimilars / biogenerics)
![]() |
Next higher product group | biopharmaceutical |
Record changed: 2019-10-11 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for DRUGS, BIOGEN, GENERICS (biosimilars / biogenerics)
- [1] Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru....
- [2] Novartis AG. (9/3/19). "Press Release: Sandoz Announces Global Deal to Commercialize Proposed Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine". Holzkirchen....
- [3] Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen....
- [4] Amgen Inc.. (10/15/18). "Press Release: Amgen Launches Amgevita (Biosimilar Adalimumab) in Markets across Europe". Thousand Oaks, CA....
- [5] Novartis AG. (7/27/18). "Press Release: Sandoz Receives European Commission Approval for Biosimilar Hyrimoz (adalimumab)". Holzkirchen....
- [6] LeanBio S.L.. (3/23/18). "Press Release: Syna Therapeutics, the New Joint Venture between LeanBio S.L. and Laboratoris Reig I Jofre"....
- [7] Novartis AG. (1/18/18). "Press Release: Sandoz Announces Exclusive Global Collaboration with Biocon on Next-generation Biosimilars". Holzkirchen....
- [8] Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich....
- [9] Novartis AG. (10/27/17). "Press Release: Sandoz Proposed Biosimilar Pegfilgrastim Accepted by EMA for Regulatory Review". Holzkirchen....
- [10] Boehringer Ingelheim. (9/15/17). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Adalimumab Biosimilar Cyltezo". Ingelheim....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top